107 related articles for article (PubMed ID: 16977258)
1. Accuracy of continuous subcutaneous glucose monitoring with the GlucoDay in type 1 diabetic patients treated by subcutaneous insulin infusion during exercise of low versus high intensity.
Fayolle C; Brun JF; Bringer J; Mercier J; Renard E
Diabetes Metab; 2006 Sep; 32(4):313-20. PubMed ID: 16977258
[TBL] [Abstract][Full Text] [Related]
2. Accuracy assessment of online glucose monitoring by a subcutaneous enzymatic glucose sensor during exercise in patients with type 1 diabetes treated by continuous subcutaneous insulin infusion.
Radermecker RP; Fayolle C; Brun JF; Bringer J; Renard E
Diabetes Metab; 2013 May; 39(3):258-62. PubMed ID: 23522730
[TBL] [Abstract][Full Text] [Related]
3. Continuous glucose monitoring during exercise in patients with type 1 diabetes on continuous subcutaneous insulin infusion.
Kapitza C; Hövelmann U; Nosek L; Kurth HJ; Essenpreis M; Heinemann L
J Diabetes Sci Technol; 2010 Jan; 4(1):123-31. PubMed ID: 20167176
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the accuracy of a microdialysis-based glucose sensor during insulin-induced hypoglycemia, its recovery, and post-hypoglycemic hyperglycemia in humans.
Rossetti P; Porcellati F; Fanelli CG; Bolli GB
Diabetes Technol Ther; 2006 Jun; 8(3):326-37. PubMed ID: 16800754
[TBL] [Abstract][Full Text] [Related]
5. Impact of physical exercise on sensor performance of the FreeStyle Libre intermittently viewed continuous glucose monitoring system in people with Type 1 diabetes: a randomized crossover trial.
Moser O; Eckstein ML; Mueller A; Birnbaumer P; Aberer F; Koehler G; Sourij C; Kojzar H; Holler P; Simi H; Pferschy P; Dietz P; Bracken RM; Hofmann P; Sourij H
Diabet Med; 2019 May; 36(5):606-611. PubMed ID: 30677187
[TBL] [Abstract][Full Text] [Related]
6. Subcutaneous glucose monitoring with GlucoDay: comparison of the results to those obtained with the endocrine artificial pancreas.
Dimitriadis G; Boutati E; Raptis AE; Hatziagelaki E; Mitrou P; Lambadiari V; Tountas N; Economopoulos T; Raptis SA
Hormones (Athens); 2010; 9(2):145-50. PubMed ID: 20687398
[TBL] [Abstract][Full Text] [Related]
7. Clinical utility of the continuous glucose monitoring system.
Bode BW
Diabetes Technol Ther; 2000; 2 Suppl 1():S35-41. PubMed ID: 11469630
[No Abstract] [Full Text] [Related]
8. Insulin-based strategies to prevent hypoglycaemia during and after exercise in adult patients with type 1 diabetes on pump therapy: the DIABRASPORT randomized study.
Franc S; Daoudi A; Pochat A; Petit MH; Randazzo C; Petit C; Duclos M; Penfornis A; Pussard E; Not D; Heyman E; Koukoui F; Simon C; Charpentier G
Diabetes Obes Metab; 2015 Dec; 17(12):1150-7. PubMed ID: 26264812
[TBL] [Abstract][Full Text] [Related]
9. Clinical performance of CGMS in type 1 diabetic patients treated by continuous subcutaneous insulin infusion using insulin analogs.
Guerci B; Floriot M; Böhme P; Durain D; Benichou M; Jellimann S; Drouin P
Diabetes Care; 2003 Mar; 26(3):582-9. PubMed ID: 12610005
[TBL] [Abstract][Full Text] [Related]
10. Comparison of a needle-type and a microdialysis continuous glucose monitor in type 1 diabetic patients.
Wentholt IM; Vollebregt MA; Hart AA; Hoekstra JB; DeVries JH
Diabetes Care; 2005 Dec; 28(12):2871-6. PubMed ID: 16306547
[TBL] [Abstract][Full Text] [Related]
11. Time Lag and Accuracy of Continuous Glucose Monitoring During High Intensity Interval Training in Adults with Type 1 Diabetes.
Li A; Riddell MC; Potashner D; Brown RE; Aronson R
Diabetes Technol Ther; 2019 May; 21(5):286-294. PubMed ID: 31017497
[No Abstract] [Full Text] [Related]
12. Evaluating the accuracy, reliability, and clinical applicability of continuous glucose monitoring (CGM): Is CGM ready for real time?
Mazze RS; Strock E; Borgman S; Wesley D; Stout P; Racchini J
Diabetes Technol Ther; 2009 Jan; 11(1):11-8. PubMed ID: 19132850
[TBL] [Abstract][Full Text] [Related]
13. Subcutaneous continuous glucose monitoring: feasibility of a new microdialysis-based glucose sensor system.
Jungheim K; Wientjes KJ; Heinemann L; Lodwig V; Koschinsky T; Schoonen AJ;
Diabetes Care; 2001 Sep; 24(9):1696-7. PubMed ID: 11522729
[No Abstract] [Full Text] [Related]
14. Continuous glucose monitoring in subcutaneous tissue using factory-calibrated sensors: a pilot study.
Hoss U; Jeddi I; Schulz M; Budiman E; Bhogal C; McGarraugh G
Diabetes Technol Ther; 2010 Aug; 12(8):591-7. PubMed ID: 20615099
[TBL] [Abstract][Full Text] [Related]
15. Microdialysis-based 48-hour continuous glucose monitoring with GlucoDay: clinical performance and patients' acceptance.
Kubiak T; Wörle B; Kuhr B; Nied I; Gläsner G; Hermanns N; Kulzer B; Haak T
Diabetes Technol Ther; 2006 Oct; 8(5):570-5. PubMed ID: 17037971
[TBL] [Abstract][Full Text] [Related]
16. Continuous subcutaneous glucose monitoring in diabetic patients: a multicenter analysis.
Maran A; Crepaldi C; Tiengo A; Grassi G; Vitali E; Pagano G; Bistoni S; Calabrese G; Santeusanio F; Leonetti F; Ribaudo M; Di Mario U; Annuzzi G; Genovese S; Riccardi G; Previti M; Cucinotta D; Giorgino F; Bellomo A; Giorgino R; Poscia A; Varalli M
Diabetes Care; 2002 Feb; 25(2):347-52. PubMed ID: 11815508
[TBL] [Abstract][Full Text] [Related]
17. The accuracy and efficacy of real-time continuous glucose monitoring sensor in patients with type 1 diabetes.
Mastrototaro J; Shin J; Marcus A; Sulur G;
Diabetes Technol Ther; 2008 Oct; 10(5):385-90. PubMed ID: 18715215
[TBL] [Abstract][Full Text] [Related]
18. The Effects of Basal Insulin Suspension at the Start of Exercise on Blood Glucose Levels During Continuous Versus Circuit-Based Exercise in Individuals with Type 1 Diabetes on Continuous Subcutaneous Insulin Infusion.
Zaharieva D; Yavelberg L; Jamnik V; Cinar A; Turksoy K; Riddell MC
Diabetes Technol Ther; 2017 Jun; 19(6):370-378. PubMed ID: 28613947
[TBL] [Abstract][Full Text] [Related]
19. Postprandial glucose monitoring in type 1 diabetes mellitus: use of a continuous subcutaneous monitoring device.
Manuel-y-Keenoy B; Vertommen J; Abrams P; Van Gaal L; De Leeuw I; Messeri D; Poscia A
Diabetes Metab Res Rev; 2004; 20 Suppl 2():S24-31. PubMed ID: 15551295
[TBL] [Abstract][Full Text] [Related]
20. Reduction in duration of hypoglycemia by automatic suspension of insulin delivery: the in-clinic ASPIRE study.
Garg S; Brazg RL; Bailey TS; Buckingham BA; Slover RH; Klonoff DC; Shin J; Welsh JB; Kaufman FR
Diabetes Technol Ther; 2012 Mar; 14(3):205-9. PubMed ID: 22316089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
